Linked Life Data

15548648

Source:http://linkedlifedata.com/resource/pubmed/id/15548648

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
46
pubmed:dateCreated
2004-11-19
pubmed:abstractText
Exposure of immature rat cerebellar granule cell cultures to the type 4 metabotropic glutamate (mGlu4) receptor enhancer N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide (PHCCC) reduced [3H]thymidine incorporation. Its action was sensitive to the growth conditions and was attenuated by two mGlu4 receptor antagonists. An antiproliferative action of PHCCC was also seen in cultures from wild-type, but not mGlu4, knock-out mice. At least in rat cultures, PHCCC was not neurotoxic and enhanced neuritogenesis. Although PHCCC reduced the increase in cAMP formation and phospho-AKT levels induced by forskolin, none of these transduction pathways significantly contributed to the reduction of [3H]thymidine incorporation. Interestingly, PHCCC reduced the expression of Gli-1, a transcription factor that mediates the mitogenic action of Sonic hedgehog. Finally, we treated newborn rats with PHCCC either intracerebrally (infusion of 5 nmol/2 microl in the cerebellar region once every other day) or systemically (5 mg/kg, i.p., once daily) from postnatal days 3-9. Local infusion of PHCCC induced substantial changes in the morphology of the developing cerebellum. In contrast, systemic injection of PHCCC induced only morphological abnormalities of the cerebellar lobule V, which became visible 11 d after the end of the treatment. These data suggest that mGlu4 receptors are involved in the regulation of cerebellar development.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
10343-52
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15548648-Animals, pubmed-meshheading:15548648-Animals, Newborn, pubmed-meshheading:15548648-Benzopyrans, pubmed-meshheading:15548648-Cell Differentiation, pubmed-meshheading:15548648-Cell Proliferation, pubmed-meshheading:15548648-Cells, Cultured, pubmed-meshheading:15548648-Cerebellum, pubmed-meshheading:15548648-Cyclic AMP, pubmed-meshheading:15548648-Depression, Chemical, pubmed-meshheading:15548648-Mice, pubmed-meshheading:15548648-Mice, Knockout, pubmed-meshheading:15548648-Neurites, pubmed-meshheading:15548648-Neurons, pubmed-meshheading:15548648-Organ Size, pubmed-meshheading:15548648-Phosphorylation, pubmed-meshheading:15548648-Protein-Serine-Threonine Kinases, pubmed-meshheading:15548648-Proto-Oncogene Proteins, pubmed-meshheading:15548648-Proto-Oncogene Proteins c-akt, pubmed-meshheading:15548648-Rats, pubmed-meshheading:15548648-Rats, Sprague-Dawley, pubmed-meshheading:15548648-Receptors, Metabotropic Glutamate, pubmed-meshheading:15548648-Signal Transduction, pubmed-meshheading:15548648-Stem Cells, pubmed-meshheading:15548648-Thymidine
pubmed:year
2004
pubmed:articleTitle
PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors.
pubmed:affiliation
Department of Human Physiology and Pharmacology, University of Rome La Sapienza, 00185 Rome, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't